ABEO ABEONA THERAPEUTICS INC.

NEUTRAL Impact: 2/10 8-K
Horizon weeks Filed Jun 10, 2026 Processed 2d 16h ago SEC 0001493152-26-028106
8-K context-dependent: Items 7.01

Price Chart

Loading chart...

Executive Summary

Abeona Therapeutics filed an 8-K furnishing an updated investor presentation (Exhibit 99.1) under Item 7.01 for use in meetings with investors and analysts. No material financial data, guidance updates, or business developments were disclosed — this is a routine disclosure of a corporate presentation used for investor relations.

Actionable Insight

The investor presentation is a routine corporate update with no new material information. Monitor for future SEC filings containing clinical pipeline updates, financial results, or regulatory catalysts for the pz-cel program.

Key Facts

  • Filed an 8-K on June 10, 2026 furnishing an updated investor presentation under Item 7.01.
  • The presentation is dated June 10, 2026 and is attached as Exhibit 99.1.
  • No financial results, guidance, material agreements, or operational updates were disclosed.
  • The filing is a routine Regulation FD disclosure for use in investor meetings.

Financial Impact

No financial impact — no material financial data or guidance was provided.

Risk Factors

  • No material information disclosed — the presentation may contain forward-looking statements with standard risk factors.
  • Biotech sector risks including clinical trial setbacks, regulatory delays, and capital needs.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-028106
Document: 0001493152-26-028106-index-headers.html0001493152-26-028106
Document: 0001493152-26-028106-index.html0001493152-26-028106
Document: 0001493152-26-028106.txt0001493152-26-028106
12 reports for ABEO
Performance horizon
Filters
Rows
Reports for ABEO — sortable, filterable
Type Now
Jun 12, 2026
1d ago
8-K
NEUTRAL ★ 2/10
$5.54 awaiting T+1awaiting T+1$5.53 (−0.18%)
Jun 10, 2026
2d ago
8-K
NEUTRAL ★ 2/10
$5.35 awaiting T+1awaiting T+1$5.53 (+3.36%)
Jun 10, 2026
3d ago
Insider Cluster
BEARISH ★ 5/10
$5.45 awaiting T+1awaiting T+1$5.53 (−1.56%)
Jun 4, 2026
9d ago
8-K
NEUTRAL ★ 4/10
$5.82 $5.46▼ −6.19%▼ −3.59%$5.53 (−4.98%)
May 22, 2026
21d ago
Insider Cluster
NEUTRAL ★ 2/10
$5.49 $5.69▲ +3.64%▲ +3.63%$5.53 (+0.73%)
May 13, 2026
4w ago
8-K
NEUTRAL ★ 5/10
$5.71 $5.60▼ −1.93%▼ −2.70%$5.53 (−3.15%)
May 13, 2026
4w ago
Press Release
NEUTRAL ★ 5/10
$5.71 $5.60▼ −1.93%▼ −2.70%$5.53 (−3.15%)
May 4, 2026
5w ago
DEFA14A
NEUTRAL ★ 2/10
$5.83 $6.01▲ +3.09%▲ +1.70%$5.53 (−5.15%)
Apr 7, 2026
9w ago
8-K
NEUTRAL ★ 3/10
$4.81 $4.87▲ +1.25%▼ −1.29%$5.53 (+14.97%)
Apr 2, 2026
10w ago
Press Release
NEUTRAL ★ 3/10
$4.82 $4.76▼ −1.24%▼ −1.72%$5.53 (+14.73%)
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (48h 25m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access